APM
IRWD icon

Avidity Partners Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Avidity Partners Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-735,000
Closed -$7.42M – 69
2020
Q1 		$7.42M Buy
+735,000
New +$8.64M 1.02% 35

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Avidity Partners Management's IRWD Position: Q2 2020 in Review

Avidity Partners Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2020, closing a stake of 735,000 shares — an estimated $7.42M sold.

Avidity Partners Management first reported a position in IRWD in Q1 2020 and held it in 1 quarter. The position peaked at $7.42M in Q1 2020. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2020.

  • Avidity Partners Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Avidity Partners Management sold 735,000 Ironwood Pharmaceuticals shares in Q2 2020, an estimated $7.42M.
  • Avidity Partners Management first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Avidity Partners Management's Ironwood Pharmaceuticals position peaked at $7.42M in Q1 2020.
  • 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2020.

Based on Avidity Partners Management's 13F filing for Q2 2020, filed 14 Aug 2020.